Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101

b3cnewswireJuly 12, 2019

Tag: SOTIO , SO-C101 , Cytune , IL-15

PharmaSources Customer Service